Completed PHASE3 INTERVENTIONAL 2-arm NCT03252925

A Safety and Efficacy Study of NAC in Patients With TA-TMA

A Safety and Efficacy Study of N-acetylcysteine in Patients With Transplant-Associated Thrombotic Microangiopathy

Sponsor: The First Affiliated Hospital of Soochow University

Conditions Hematologic Diseases Thrombotic Microangiopathies

Interventions N-Acetylcysteine Placebo Oral Tablet

Updated 7 times since 2017 Last updated: Jan 19, 2022 Started: Nov 1, 2017 Primary completion: Oct 1, 2021 Completion: Oct 1, 2021

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A PHASE3 clinical study on Hematologic Diseases and Thrombotic Microangiopathies, this trial is completed. The trial is conducted by The First Affiliated Hospital of Soochow University and has accumulated 7 data snapshots since 2017. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.

Status Flow

Change History

7 versions recorded

Sep 2024 — Present [monthly]

Completed PHASE3
Jul 2024 — Sep 2024 [monthly]

Completed PHASE3
Mar 2022 — Jul 2024 [monthly]

Completed PHASE3

Status: Unknown Status → Completed
Jan 2021 — Mar 2022 [monthly]

Unknown Status PHASE3
Jul 2020 — Jan 2021 [monthly]

Unknown Status PHASE3

Status: Recruiting → Unknown Status

▶ Show 2 earlier versions

Jun 2018 — Jul 2020 [monthly]

Recruiting PHASE3
Sep 2017 — Jun 2018 [monthly]

Recruiting PHASE3

First recorded

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

The First Affiliated Hospital of Soochow University

Data source: The First Affiliated Hospital of Soochow University

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Suzhou, China